Last updated on September 2016

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma


Brief description of study

Pembrolizumab + Epacadostat or Placebo in Subjects with Unresectable or Metastatic Melanoma

Detailed Study Description

The purpose of the study is to assess the efficacy, safety, and tolerability when combining pembrolizumab with epacadostat or placebo in subjects with unresectable or metastatic melanoma.

Clinical Study Identifier: TX145132

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )